Trial Outcomes & Findings for RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos) (NCT NCT05910879)
NCT ID: NCT05910879
Last Updated: 2026-08-12
Results Overview
Coronavirus-Related eHealth Literacy Scale (CoV-eHEALS) is an 8-item measure assessing an individual's self-rated ability to use the internet to find and utilize health information about the coronavirus. Each item is rated on a 5-point Likert scale (1 to 5), and a mean score is calculated (range 1-5), with higher scores indicating greater eHealth literacy (better outcome).
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
625 participants
Primary outcome timeframe
30 days post-intervention
Results posted on
2026-08-12
Participant Flow
Participants were recruited at Mexican Consulate events, through in-person engagement and community partnerships.
Participants were recruited at Mexican Consulate events and provided consent prior to assignment. The pilot phase and cluster randomized trial phase enrolled separate participant cohorts. In the cluster randomized trial phase, events (clusters), rather than individual participants, were randomized to study conditions.
Unit of analysis: Mexican Consulate event
Participant milestones
| Measure |
CRT: Promotores Health Education Only
The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.
|
CRT: SAII + Promotores Health Education
The Self-Affirmation Implementation Intentions (SAII) Intervention is designed to reduce stigma and enhance uptake of health messaging and includes (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance. In a brief exercise, participants are asked to provide a personal story and positive experience during the COVID19 pandemic. The self-affirmation is designed to offset effects of threats to self. In the next section participants are asked to formulate an if-then plan with one preferred self-affirmation-inducing cognition. After selecting response, participants read the full If-Then plan out loud and are provided with a paper copy of their exercise to take home.
Promotores de Salud (Health Education): The Promotores de Salud intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
|
Pilot Phase: SAII
The pilot phase included administration of the SAII to bicultural, bilingual staff members (n = 5) and to community members at a Mexican Consulate event (n = 20).
|
|---|---|---|---|
|
Period 1: Pilot Phase
STARTED
|
0 0
|
0 0
|
25 0
|
|
Period 1: Pilot Phase
COMPLETED
|
0 0
|
0 0
|
25 0
|
|
Period 1: Pilot Phase
NOT COMPLETED
|
0 0
|
0 0
|
0 0
|
|
Period 2: Cluster Randomized Trial
STARTED
|
335 16
|
265 16
|
0 0
|
|
Period 2: Cluster Randomized Trial
COMPLETED
|
335 16
|
265 16
|
0 0
|
|
Period 2: Cluster Randomized Trial
NOT COMPLETED
|
0 0
|
0 0
|
0 0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
Baseline characteristics by cohort
| Measure |
CRT: Promotores Health Education Only
n=335 Participants
The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.
|
CRT: SAII + Promotores Health Education
n=265 Participants
The Self-Affirmation Implementation Intentions (SAII) Intervention is designed to reduce stigma and enhance uptake of health messaging and includes (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance. In a brief exercise, participants are asked to provide a personal story and positive experience during the COVID19 pandemic. The self-affirmation is designed to offset effects of threats to self. In the next section participants are asked to formulate an if-then plan with one preferred self-affirmation-inducing cognition. After selecting response, participants read the full If-Then plan out loud and are provided with a paper copy of their exercise to take home.
Promotores de Salud (Health Education): The Promotores de Salud intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
|
Pilot Phase: SAII
The pilot phase included administration of the SAII to bicultural, bilingual staff members (n = 5) and to community members at a Mexican Consulate event (n = 20).
|
Total
n=600 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
42.64 years
STANDARD_DEVIATION 13.11 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
40.85 years
STANDARD_DEVIATION 12.76 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
41.85 years
STANDARD_DEVIATION 12.98 • n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Sex/Gender, Customized
Sex at birth · Female
|
239 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
182 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
421 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Sex/Gender, Customized
Sex at birth · Male
|
94 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
81 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
175 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Sex/Gender, Customized
Sex at birth · Unknown
|
2 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
2 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
4 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
306 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
241 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
547 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
13 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
8 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
21 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
16 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
16 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
32 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
4 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
8 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
12 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
0 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
2 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
0 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
0 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
0 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
0 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Race (NIH/OMB)
White
|
106 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
86 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
192 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Race (NIH/OMB)
More than one race
|
7 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
3 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
10 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
216 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
168 Participants
n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
384 Participants
n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Region of Enrollment
United States
|
335 participants
n=1 Participants
|
265 participants
n=1 Participants
|
—
|
600 participants
n=2 Participants
|
|
Vaccine Hesitancy/Acceptance
|
4.78 units on a scale
STANDARD_DEVIATION 1.2 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
4.78 units on a scale
STANDARD_DEVIATION 1.14 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
4.78 units on a scale
STANDARD_DEVIATION 1.17 • n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Coronavirus-Related eHealth Literacy Scale (CoV-eHEALS)
|
3.80 units on a scale
STANDARD_DEVIATION 1.06 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
3.83 units on a scale
STANDARD_DEVIATION 1.05 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
3.81 units on a scale
STANDARD_DEVIATION 1.06 • n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
COVID-19 Knowledge & Attitudes (KAPs)
|
3.28 units on a scale
STANDARD_DEVIATION 0.98 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
3.21 units on a scale
STANDARD_DEVIATION 0.93 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
3.25 units on a scale
STANDARD_DEVIATION 0.96 • n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
|
Broadband Internalizing Symptoms
|
1.61 units on a scale
STANDARD_DEVIATION 0.81 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
1.67 units on a scale
STANDARD_DEVIATION 0.86 • n=1 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
—
|
1.64 units on a scale
STANDARD_DEVIATION 0.83 • n=2 Participants • Participants in the pilot phase were included in the study enrollment; however, baseline demographic data were not collected because data collection was conducted anonymously. Therefore, no participants from the pilot phase are included in the analysis population for this measure.
|
PRIMARY outcome
Timeframe: At enrollment (single time point)Population: Outcome data were not collected for the pilot phase; therefore, no participants from the pilot phase are included in the analysis population for this measure.
Participants are offered to take home 0-4 SARS-CoV-2 rapid home test kits after enrolling in the project. The primary hypothesis focuses on increasing the likelihood a participant will take home testing kits for COVID-19. After the Promotores only intervention or the Promotores plus SAII intervention, the number or test kits participants choose to take home are recorded.
Outcome measures
| Measure |
CRT: Promotores Health Education Only
n=335 Participants
The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.
|
CRT: SAII + Promotores Health Education
n=265 Participants
The Self-Affirmation Implementation Intentions (SAII) Intervention is designed to reduce stigma and enhance uptake of health messaging and includes (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance. In a brief exercise, participants are asked to provide a personal story and positive experience during the COVID19 pandemic. The self-affirmation is designed to offset effects of threats to self. In the next section participants are asked to formulate an if-then plan with one preferred self-affirmation-inducing cognition. After selecting response, participants read the full If-Then plan out loud and are provided with a paper copy of their exercise to take home.
Promotores de Salud (Health Education): The Promotores de Salud intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
|
Pilot Phase: SAII
The pilot phase included administration of the SAIl to bicultural, bilingual staff members (n = 5) and to community members at a Mexican Consulate event (n = 20).
|
|---|---|---|---|
|
Rapid Testing Acceptance
|
2.8 Test Kits
Standard Deviation 1.43
|
2.9 Test Kits
Standard Deviation 1.44
|
—
|
PRIMARY outcome
Timeframe: 30 days post-interventionPopulation: The number analyzed reflects participants with valid data for this outcome at follow-up. Participants may differ across outcome measures depending on data availability. Outcome data were not collected for the pilot phase; therefore, no participants from the pilot phase are included in the analysis population for this measure.
Attitudes toward COVID-19 vaccines were assessed at 30-day follow-up using the Vaccine Acceptance scale from the RADx Common Data Elements and project-specific measures. The scale includes 7 items rated on a 6-point Likert scale ranging from 1 (Strongly Agree) to 6 (Strongly Disagree). Items were reverse coded, and a mean score was calculated (range 1-6), with higher scores indicating greater vaccine acceptance (better outcome).
Outcome measures
| Measure |
CRT: Promotores Health Education Only
n=283 Participants
The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.
|
CRT: SAII + Promotores Health Education
n=221 Participants
The Self-Affirmation Implementation Intentions (SAII) Intervention is designed to reduce stigma and enhance uptake of health messaging and includes (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance. In a brief exercise, participants are asked to provide a personal story and positive experience during the COVID19 pandemic. The self-affirmation is designed to offset effects of threats to self. In the next section participants are asked to formulate an if-then plan with one preferred self-affirmation-inducing cognition. After selecting response, participants read the full If-Then plan out loud and are provided with a paper copy of their exercise to take home.
Promotores de Salud (Health Education): The Promotores de Salud intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
|
Pilot Phase: SAII
The pilot phase included administration of the SAIl to bicultural, bilingual staff members (n = 5) and to community members at a Mexican Consulate event (n = 20).
|
|---|---|---|---|
|
Vaccine Hesitancy/Acceptance
|
4.69 units on a scale
Standard Deviation 1.2
|
4.78 units on a scale
Standard Deviation 1.02
|
—
|
PRIMARY outcome
Timeframe: 30 days post-interventionPopulation: The number analyzed reflects participants with valid data for this outcome at follow-up. Participants may differ across outcome measures depending on data availability. Outcome data were not collected for the pilot phase; therefore, no participants from the pilot phase are included in the analysis population for this measure.
Coronavirus-Related eHealth Literacy Scale (CoV-eHEALS) is an 8-item measure assessing an individual's self-rated ability to use the internet to find and utilize health information about the coronavirus. Each item is rated on a 5-point Likert scale (1 to 5), and a mean score is calculated (range 1-5), with higher scores indicating greater eHealth literacy (better outcome).
Outcome measures
| Measure |
CRT: Promotores Health Education Only
n=281 Participants
The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.
|
CRT: SAII + Promotores Health Education
n=264 Participants
The Self-Affirmation Implementation Intentions (SAII) Intervention is designed to reduce stigma and enhance uptake of health messaging and includes (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance. In a brief exercise, participants are asked to provide a personal story and positive experience during the COVID19 pandemic. The self-affirmation is designed to offset effects of threats to self. In the next section participants are asked to formulate an if-then plan with one preferred self-affirmation-inducing cognition. After selecting response, participants read the full If-Then plan out loud and are provided with a paper copy of their exercise to take home.
Promotores de Salud (Health Education): The Promotores de Salud intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
|
Pilot Phase: SAII
The pilot phase included administration of the SAIl to bicultural, bilingual staff members (n = 5) and to community members at a Mexican Consulate event (n = 20).
|
|---|---|---|---|
|
Coronavirus-Related eHealth Literacy Scale (CoV-eHEALS)
|
4.00 units on a scale
Standard Deviation 0.83
|
3.83 units on a scale
Standard Deviation 1.05
|
—
|
PRIMARY outcome
Timeframe: 30 days post-interventionPopulation: The number analyzed reflects participants with valid data for this outcome at follow-up. Participants may differ across outcome measures depending on data availability. Outcome data were not collected for the pilot phase; therefore, no participants from the pilot phase are included in the analysis population for this measure.
The COVID-19 Knowledge \& Attitudes (KAPs) measure assesses respondents' knowledge and attitudes about COVID-19. The scale includes 7 items rated on a 5-point scale ranging from 1 (Definitely False) to 5 (Definitely True). A mean score is calculated (range 1-5), with higher scores indicating greater knowledge and more favorable attitudes (better outcome).
Outcome measures
| Measure |
CRT: Promotores Health Education Only
n=281 Participants
The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.
|
CRT: SAII + Promotores Health Education
n=221 Participants
The Self-Affirmation Implementation Intentions (SAII) Intervention is designed to reduce stigma and enhance uptake of health messaging and includes (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance. In a brief exercise, participants are asked to provide a personal story and positive experience during the COVID19 pandemic. The self-affirmation is designed to offset effects of threats to self. In the next section participants are asked to formulate an if-then plan with one preferred self-affirmation-inducing cognition. After selecting response, participants read the full If-Then plan out loud and are provided with a paper copy of their exercise to take home.
Promotores de Salud (Health Education): The Promotores de Salud intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
|
Pilot Phase: SAII
The pilot phase included administration of the SAIl to bicultural, bilingual staff members (n = 5) and to community members at a Mexican Consulate event (n = 20).
|
|---|---|---|---|
|
COVID-19 Knowledge & Attitudes (KAPs)
|
3.28 units on a scale
Standard Deviation 0.84
|
3.42 units on a scale
Standard Deviation 0.83
|
—
|
SECONDARY outcome
Timeframe: 30 days post-interventionPopulation: The number analyzed reflects participants with valid data for this outcome at follow-up. Participants may differ across outcome measures depending on data availability. Outcome data were not collected for the pilot phase; therefore, no participants from the pilot phase are included in the analysis population for this measure.
Depression and anxiety symptoms were assessed using the PhenX Toolkit measures, including 2 items for depression and 2 items for anxiety. Participants reported how often they had been bothered by each problem during the past 2 weeks. Items were rated on a scale from 0 (None/not at all) to 4 (Severe/nearly every day). A mean score was calculated across the 4 items (range 0-4), with higher scores indicating greater symptom severity (worse outcome).
Outcome measures
| Measure |
CRT: Promotores Health Education Only
n=282 Participants
The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.
|
CRT: SAII + Promotores Health Education
n=221 Participants
The Self-Affirmation Implementation Intentions (SAII) Intervention is designed to reduce stigma and enhance uptake of health messaging and includes (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance. In a brief exercise, participants are asked to provide a personal story and positive experience during the COVID19 pandemic. The self-affirmation is designed to offset effects of threats to self. In the next section participants are asked to formulate an if-then plan with one preferred self-affirmation-inducing cognition. After selecting response, participants read the full If-Then plan out loud and are provided with a paper copy of their exercise to take home.
Promotores de Salud (Health Education): The Promotores de Salud intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation.
|
Pilot Phase: SAII
The pilot phase included administration of the SAIl to bicultural, bilingual staff members (n = 5) and to community members at a Mexican Consulate event (n = 20).
|
|---|---|---|---|
|
Broadband Internalizing Symptoms
|
1.53 units on a scale
Standard Deviation 0.80
|
1.65 units on a scale
Standard Deviation 0.93
|
—
|
Adverse Events
CRT: Promotores Health Education Only
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
CRT: SAII + Promotores Health Education
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Pilot Phase: SAII
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Kelsey Van Brocklin, Project Coordinator
University of Oregon
Phone: 541-346-9530
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place